Treatment-induced mucositis: an old problem with new remedies
1998

New Treatments for Mucositis Caused by Cancer Therapy

Sample size: 275 publication Evidence: moderate

Author Information

Author(s): RP Symonds

Primary Institution: Beatson Oncology Centre, Western Infirmary, Glasgow, UK

Hypothesis

Can new agents effectively reduce mucositis caused by chemotherapy and radiotherapy?

Conclusion

New treatments, including granulocyte colony-stimulating factor and antibiotic pastilles, can significantly reduce mucositis and associated weight loss during cancer treatment.

Supporting Evidence

  • Antibiotic pastilles reduced mucositis distribution and weight loss during treatment.
  • Granulocyte colony-stimulating factor significantly reduced the incidence of mucositis in patients.
  • Mechanical cleansing with saline was found to be the most effective traditional measure.

Takeaway

Mucositis is a painful side effect of cancer treatment, but new medicines can help make it less severe.

Methodology

The study involved randomized controlled trials comparing various treatments for mucositis in patients undergoing chemotherapy and radiotherapy.

Limitations

The optimal dosage and administration methods for some treatments are still not known.

Participant Demographics

Patients undergoing chemotherapy and radiotherapy for head and neck cancer.

Statistical Information

P-Value

0.002

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication